{"product_id":"kidney-disease-clinical-trialists-workshop-9th-edition-2025","title":"Kidney Disease Clinical Trialists Workshop 9th Edition 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"outer-wrapper\"\u003e\n\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\n\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\n\u003csection class=\"product\"\u003e\n\u003csection class=\"content-item-container-section\"\u003e\n\u003csection class=\"content\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\n\u003ch3\u003e\u003cstrong\u003e Kidney Disease Clinical Trialists Workshop 9th Edition 2025\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eInclude: 4 videos, size: 57.5 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Target Audience: nephrologists, internists\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eApril 4-5, 2025\u003cbr\u003e\nEmbassy of France, Washington DC\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (up to 130) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R\u0026amp;D pharma, patient representatives and device companies, NIH, EMA, PMDA and FDA experts.\u003c\/p\u003e\n\u003cp\u003eThe KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.\u003c\/p\u003e\n\u003cp\u003eOur objectives are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003e9th Edition of the Kidney Disease Clinical Trialists (KDCT) Workshop 2025\u003c\/strong\u003e is tailored for a highly specialized group of physicians and researchers involved in kidney disease clinical trials. The core physician audience includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eNephrologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical trialists\u003c\/strong\u003e and \u003cstrong\u003eprincipal investigators\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcademic researchers\u003c\/strong\u003e in nephrology and internal medicine\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhysicians from regulatory bodies\u003c\/strong\u003e (e.g., NIH, EMA, PMDA, FDA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical professionals\u003c\/strong\u003e from R\u0026amp;D in pharma and device companies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis workshop is a \u003cstrong\u003ehigh-level think tank\u003c\/strong\u003e with a limited number of attendees (up to 130), designed to foster international collaboration on trial design, ethics, biomarkers, and regulatory strategies for kidney disease interventions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eApril 4 Initial Track.mp4\u003cbr\u003e\nApril 4 Parallel Track.mp4\u003cbr\u003e\nApril 5 Initial Track.mp4\u003cbr\u003e\nApril 5 Parallel Track.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e* Detail:\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/images.squarespace-cdn.com\/content\/v1\/5a7c1cb78dd041a5e11c9f6b\/6ead8374-fe8e-42e8-bed6-7abf31b1dd3b\/KDCT+2025+Preliminary+Program+at+a+glance+%285%29.png\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954575249506,"sku":"MED-AMB06444","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Kidney-Disease-Clinical-Trialists-Workshop-9th-Edition-2025.jpg?v=1779380027","url":"https:\/\/meducourse.com\/products\/kidney-disease-clinical-trialists-workshop-9th-edition-2025","provider":"Meducourse","version":"1.0","type":"link"}